New targets for therapeutic attack

被引：9

作者：

Wakeling, AE

Barker, AJ

Davies, DH

Brown, DS

Green, LR

Cartlidge, SA

Woodburn, JR

机构：

来源：

关键词：

D O I：

10.1677/erc.0.0040351

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：351 / 355

页数：5

共 18 条

[1]

BARKER AJ, 1992, Patent No. 520722

[2] 4,5-DIANILINOPHTHALIMIDE - A PROTEIN-TYROSINE KINASE INHIBITOR WITH SELECTIVITY FOR THE EPIDERMAL GROWTH-FACTOR RECEPTOR SIGNAL-TRANSDUCTION PATHWAY AND POTENT IN-VIVO ANTITUMOR-ACTIVITY [J].

BUCHDUNGER, E ;

TRINKS, U ;

METT, H ;

REGENASS, U ;

MULLER, M ;

MEYER, T ;

MCGLYNN, E ;

PINNA, LA ;

TRAXLER, P ;

LYDON, NB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) :2334-2338

[3]

BURKE T R JR, 1992, Drugs of the Future, V17, P119

[4] THE EGF RECEPTOR SYSTEM AS A TARGET FOR ANTITUMOR THERAPY [J].

ENNIS, BW ;

LIPPMAN, ME ;

DICKSON, RB .

CANCER INVESTIGATION, 1991, 9 (05) :553-562

[5] A SPECIFIC INHIBITOR OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR TYROSINE KINASE [J].

FRY, DW ;

KRAKER, AJ ;

MCMICHAEL, A ;

AMBROSO, LA ;

NELSON, JM ;

LEOPOLD, WR ;

CONNERS, RW ;

BRIDGES, AJ .

SCIENCE, 1994, 265 (5175) :1093-1095

[6] PHARMACEUTICAL RESEARCH IN MOLECULAR ONCOLOGY [J].

GIBBS, JB ;

OLIFF, A .

CELL, 1994, 79 (02) :193-198

[7] PREVALENCE OF ABERRANT EXPRESSION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR IN HUMAN CANCERS [J].

GULLICK, WJ .

BRITISH MEDICAL BULLETIN, 1991, 47 (01) :87-98

[8] Eukaryotic protein kinases [J].

Hanks, Steven K. .

CURRENT OPINION IN STRUCTURAL BIOLOGY, 1991, 1 (03) :369-383

[9] SH2 AND SH3 DOMAINS - ELEMENTS THAT CONTROL INTERACTIONS OF CYTOPLASMIC SIGNALING PROTEINS [J].

KOCH, CA ;

ANDERSON, D ;

MORAN, MF ;

ELLIS, C ;

PAWSON, T .

SCIENCE, 1991, 252 (5006) :668-674

[10]

POWIS G, 1994, ANTI-CANCER DRUG DES, V9, P263

← 1 2 →